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 Diabetes is a disease that affects millions of people from children to older adults.  There 
is no cure, although it can be managed to prevent complications. Education of student nurses is 
where they are born and raised to become nurses who save and change lives. Teaching student 
nurses in depth about diabetes as a disease and the treatments that best fit their specific needs is 
where educating patients begins. Learning about a secondary option for blood glucose checks 
can make all the difference for several patients. Multiple finger sticks daily has been the leading 
way to check blood sugar for years.  Even with multiple checks hypoglycemia and 
hyperglycemia can be undetected in a timely manner. Having continuous glucose monitoring 
(CGM) especially for patients that are asymptomatic when hypoglycemic can prevent episodes 
and improve quality of life (Beck et. al, 2017).  
Approaching the faculty at the University of Texas at Tyler with this research is meant to 
persuade them to include the CGM in the curriculum and to invest in some of the CGM for 
simulation lab and hands on experience for the students. Gaining support from the faculty and 
the board will be important to get the budget for the supplies for the hands-on learning in the 
simulation lab. Making changes to the curriculum will not be overwhelming to add the option so 
students are able to advocate for their patients in clinicals and once they graduate. Currently 
students are taught finger sticks for blood glucose and education regarding multiple sticks a day 
and symptoms of high and low glucose. Implementing this project now and sustaining it will 
give the future generation of nurse’s knowledge allowing them to educate the nurses already in 
the workforce who are unaware. The student nurses that are sent into the healthcare system must 
be well educated in different treatments for diabetes especially as it affects millions of people 
completely differently.  
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1. Rationale for the Project 
Diabetes is a disease that puts severe restrictions on a patient’s quality of life.  While 
diabetes can be managed, it has required flash glucose monitoring (FGM) to trend blood glucose 
multiple times every day.  Even then extreme lows and highs can happen putting a patient’s life 
in danger.  Relying on finger sticks means equipment must be available, sleep disrupted, and 
daily activities impacted. A continuous glucose monitoring (CGM) system is now available to 
patients with diabetes that attaches to the upper arm staying in place for up to 14 days (Reddy et 
al., 2018).  A scanner is used to read the device and upload the blood glucose data to an 
application.  This monitors continuously allowing freedom of patients from relying on finger 
sticks while also giving critical information in real time (Colas et al., 2018).  It will also increase 
patient compliance and satisfaction in managing their disease.  
CGM works for patients with type 1 and type 2 diabetes.  For all patients with diabetes 
the ease of mind and efficiency of scanning the applied arm device will not only put the patient’s 
and family’s minds at ease but save lives.  The ease of monitoring allows for patients and family 
members to discreetly check blood glucose without the need to carry multiple supplies around. 
Broyd (2017) explains that the sensor in the Freestyle Libre CGM attaches to the arm and inserts 
into the interstitial fluid to monitor glucose levels and is read by scanning the device with a 
scanner or smartphone.  Broyd (2017) continues to explain that FGM only indicates where your 
blood glucose levels are and the CGM system gives an 8-hour trend to track glucose for a more 
effective way to manage the disease.  
1.1 Project Goals 
The goals of this benchmark project are to educate faculty, student nurses, nurses, and the 
community. The awareness that is needed to improve diabetic patient’s quality of life and 
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outcome scenarios is vital. The concept of bringing CGM to student nurses allows for the future 
of nursing to have this ability to advocate for patients as well as educate on a wide spectrum. My 
primary goal is to get the faculty on board to add CGM into the curriculum as well as getting a 
budget for CGMs for practice in simulation lab. This gives hands on experience and will help the 
students retain knowledge in the future (Broyd, 2017). The end goal from the implementation of 
this project is for patients to have more control in their life with managing diabetes. This can 
look like many things to many different patients. Some will have increased compliance because 
finger sticks is difficult to remember, carry around, or physically perform. Some will have 
decreased hypoglycemic episodes because they are asymptomatic, and this will help alert them 
preventing serious complications. Some patients, if not all, will have improved HbA1c numbers 
due to the consistent picture CGM paints allowing adjustment improvements to insulin and 
medication needs. Some families will have less anxiety, especially in the pediatric population 
because when parents need to check a blood sugar in the middle of the night, they don’t have to 
wake their child. Scanning the arm device instead of constant finger sticks is beneficial in so 
many more ways than listed above. The goal is to keep patients from having hypoglycemia, but 
the benefit is also improved quality of life.  
2. Literature Discussion to Support Project 
The process for searching evidence-based practice related to CGM was done through 
multiple databases for thorough research. Keywords included continuous glucose monitoring, 
flash glucose monitoring, hypoglycemia, accuracy, and diabetes. Exclusion criteria included 
pediatrics and obstetrics. Medline database search resulted in nine articles. CINAHL database 
search resulted in 14 articles. Cochrane database search resulted in 17 articles for review. Of 
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these databases and articles found, the 12 in use were determined to contain data that supported 
the change project.  
Reddy et al. (2018) outlines a pilot study comparing CGM to FGM in effectiveness of 
decreasing time spent in hypoglycemia as well as number of events. The results indicated that 
CGM decreases time spent out of ideal glucose range. Furthermore, an extension phase was 
completed with both groups using CGM for comparison. The results from both studies provide 
evidence that CGM decreases time in hypoglycemia, decreases hypoglycemic events, and 
reduces fear of hypoglycemia (Reddy et al., 2018). A randomized control trial (RCT) with ICU 
patients was done to determine if CGM provides improved glucose control while also indicating 
that it was more cost effective between supplies and nursing time (Boom et al., 2014). Boom et 
al. (2014) determined that CGM was a safe and effective procedure to use for glucose 
monitoring. Aleppo et al. (2017) verified through a study of CGM and CGM plus FGM that 
CGM is just as safe and effective for glucose results without needing to continuously verify 
glucose levels by FGM. This is an important study to the PICOT in question because patient 
safety is vital. Lu, Zuo, Guo, Wen, and Kang (2018) studied CGM versus FGM in critically ill 
patients and verified that CGM decreases number of hypoglycemic events as well as time in 
hypoglycemia.  
Colas et al. (2018) was an observational study done outpatient that proved using CGM as 
preventative measures in patients that were high risk due to hypertension by monitoring blood 
glucose allowed patients to be diagnosed quickly, reduce the risk of diagnosis, and improved 
blood glucose levels in those that were pre-diabetic. This is a significant study to consider 
because diabetes is silent until it is at a critical level that puts the patient’s health in danger. Beck 
et al. (2017) is a RCT over a two-year period of 24 different outpatient centers that led to the 
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conclusion that patients had fewer hypoglycemic events when using CGM vs. FGM. Vloemans 
et al. (2017) is a qualitative study that followed an RCT about the patient’s perception of quality 
of life using the CGM and the data showed patient’s preferred CGM, felt safer, had improved 
glucose levels, and a general sense of improved quality of life.  
Little et al. (2018) did a RCT and a follow up RCT to track how the patients responded 
after the clinical trial using CGM was complete. The initial RCT done by Little et al. (2018) was 
done over a 24-week period and supported CGM improved glucose levels while decrease 
hypoglycemic events. The secondary trial Little et al. (2018) gives insight to how well a sample 
of the original trial responded to CGM after the trial ended and while the sample was small, it 
showed a trend in patients continuing to use the CGM as the preferred method. These studies 
were done on Type 1 diabetics only, however they are more sensitive to hypoglycemic events 
due to the nature of the disease (Broyd, 2017). Vigersky et al. (2012) is a RCT on type 2 
diabetics that were not on prandial insulin and were placed on CGM vs FGM. This study led to 
the conclusion that CGM helped patients stay in range without prandial insulin if the patients 
adjusted their diet, exercise, weight loss, and other factors appropriately. This mean pre-
diabetics, current diabetics managed on diet and exercise, and diabetic managed on oral 
medication have to ability to increase their control over their glucose range so they can prevent 
further medication needs as well as improve or reverse their diabetes. This is major in the world 
of diabetes as a chronic and severe disease in the USA.  
Pickup, Freeman, and Sutton (2011) is a meta-analysis of six RCTs that is a critical 
component to this project because it showed consistent proof that CGM improve glucose levels 
overall and decrease hypoglycemic events. Meta-analysis is important to use in research to add 
more value to evidence-based practice research.  
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3. Project Stakeholders 
Project stakeholders are invaluable to any project, creation, management, or 
organizational structure. When it come to diabetics and healthcare the stakeholders are many. 
The patients are huge stakeholders in the process of getting the best treatment plan for their 
needs. Physicians, diabetic educators, nurses, and healthcare workers are stakeholders in what 
evidence-based practice is the best for individualized treatment as the world of healthcare 
advances. For this change project to be started in a university the faculty, board of directors, 
students, and preceptors of the student nurses are vital stakeholders that will make the change 
happen in a way that will be sustainable. Involvement of the dean and the director of nursing will 
be important to get the budget approved to get some CGMs for simulation lab for practice and 
hands on learning. Case managers, Medicaid, Medicare, and insurance companies will be 
important to know what the cost options are for the patients. Last, but definitely one of the most 
important stakeholders are the patients and their families. This directly affects their lives and 
improving the quality of life is what nurses and healthcare workers aim for with their patients.  
4. Proposed Outcomes 
The FDA has approved four different devices to use as continuous glucose monitors as of 
2018 (Wolinsky, 2018). The necessity of FDA approved devices is imperative to safety and the 
ability to get the CGM set up for patients. The reality of diminishing painful and constant finger 
sticks for patients is an important factor in the future of diabetic treatment plans. The outcomes 
anticipated by implementing the change project is in a way that is sustainable. The first proposed 
outcome would be for the faculty to be fully educated and describe the curriculum change. The 
second outcome would be to have the equipment in the simulation lab for the faculty to use as an 
educational tool for enhanced learning. The third outcome would be the implementation of the 
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education in the diabetes portion of the curriculum. The fourth outcome would be for students to 
understand the education and describe different situations that CGM would be appropriate for 
through a case study scenario. The fifth outcome would be for the students to take the education 
to clinicals and if they have patients that are appropriate for CGM they will talk to their 
preceptor and educate them if needed on the benefit for a discharge CGM prescription. The last 
outcome would be for the faculty to evaluate how effective the education and simulation is and 
make appropriate alterations as necessary. The end goal is for students to take this education into 
the real world even after graduation to be advocates for their patients as EBP continuously 
changes. Nurses learn to go with the flow, or they become overwhelmed quickly. The learning 
and change of different methods or protocols never ends for the benefit of all stakeholders 
involved.  
5. Evaluation Design 
Evaluation is a critical process of any change action plan or implementation plan. There 
are multiple evaluation methods that can be used depending on what is being implemented. The 
plan for the change project is for patients with diabetes to have improved quality of life and 
improved health outcomes. By using a continuous glucose monitoring (CGM) device, patients 
have less hypoglycemic events, improved glucose range, and improved quality of life by ease of 
access and a constant trend in data for healthcare providers (Beck et al, 2017). By keeping 
patients who are asymptomatic from going into hypoglycemia many things are prevented such as 
risk of death, coma, or injury (Colas et al., 2018). Also, having improved glucose levels on a 
general level decrease risk of secondary comorbidities (Colas, et al., 2018). This means that 
using the EBP of CGM by teaching students from now on will impact the future widely for 
diabetic patients. Student nurses are taught to advocate for their patients and educate their 
EFFECTIVE GLUCOSE MONITORING   11 
 
patients. Diabetes affects millions of people around the world and is a disease that when treated 
appropriately doesn’t cause secondary comorbidities (Polit & Beck, 2017). Mapping out what the 
reality looks like from concept to implementation involves nominal scale questionnaires to be 
used for the staff and the students at different intervals. Bar chart graphs will be used to show 
visual charts. Evaluation of whether the implementation was successful is a multistep process. 
Educating students to the benefits of CGM vs. FGM is part of teaching the future generation 
improved methods of treatment. Evaluation surveys are nominal scales using yes/no/not 
applicable/unknown with a comment section available. A bar chart graph for statistical analysis 
will be completed based on all the tools and surveys used. A bar chart will compare data of the 
answers and different categories and as time increases is ideal for showing large data points 
(Polit & Beck, 2017). Using inferential statistics is an important step in the evaluation process 
because it allows for conclusions to be drawn (Polit & Beck, 2017). Ideally the conclusion will 
be that CGM education is beneficial and effective.   
6. Timetable/Flowchart 
In the previous 4 semesters the change project question was designed based on the 
concern for the number of patients seen in the hospital with unmanaged diabetes due to different 
reasons. This led to the PICOT: In patients with diabetes (P) how does continuous glucose 
monitoring system (I) compared with flash glucose monitoring systems (C) affect catching 
hypoglycemia in patients who are asymptomatic (O) over a 3-month period (T)?  This is an 
intervention PICOT question that allows for a thorough research of evidence-based practice to 
find the best practice to catch hypoglycemic episodes. This has changed slightly to include direct 
education in the school of nursing undergraduate BSN program instead of implementing it in the 
hospital directly as initially anticipated. Ideally the change project will be brought up during the 
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summer semester of 2020 to be worked through step by step to start implementation in the Fall 
of 2020 curriculum. The benchmark was supposed to be brought up this semester to present but 
due to the circumstances of the coronavirus and complete change of education to get the students 
what they need through the semester including clinical hours it was postponed.  
7. Data Collection Methods 
Data collection started with evidence-based research and deciding which studies were of 
high quality to the question at hand. Using an evaluation table, synthesis table, and other tools 
strengths and weaknesses were laid out and considered. It was important to use a variety of 
studies such as meta-analysis, qualitative, randomized control trials, follow up studies to trials 
completed, and trials for patients who were at risk due to hypertension. Collection of data 
through the evaluative tools once implemented will give insight to the strengths and weaknesses 
of the implementation after it is approved by the university. The faculty will be responsible to 
ensure education is thorough and evaluation tools are completed. Having open comment sections 
on the evaluation tools for both the faculty after education and for the students intermittently 
before, during, and after clinicals will allow for adjustments in the process.  
8. Discussion of Evaluation 
This is a benchmark study so there is no evaluation to discuss. The studies found and 
change project have been met with excitement and excellent feedback in different areas of 
nursing. A home health agency has expressed interest in the idea and has a nurse that is 
advocating for her patients after feedback on the concept. The faculty colleagues who have been 
able to hear the concept prior to the canceled meeting were intrigued and look forward to hearing 
the full change project. It is backed by evidence-based research very clearly and has a strong 
value behind it.  
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9. Cost/Benefits 
The cost and benefits are factors that must be considered when proposing a new plan and idea. 
Cost includes purchase of at least 2-10 CGM machines and the strips that are used to check the 
glucose levels. Evaluations can be printed out which means cost of paper, ink, and other things. 
Evaluations ideally would be done with a computer so it will be set up to automatically to gather 
and group the data in a pattern. The cost of adding the education to the curriculum wouldn’t cost 
anything but the faculties time, as they are generally paid on salary. Curriculum changes happen 
each semester in forms of updates and edits anyway. The cost for any printed papers, pens, or 
office supplies may run up to $100. The CGM machines can be up to $1000 each, however there 
are discounts and a representative of different companies would be spoken with to see if they 
would be willing to donate or give a discount.  
 When the benefits are considered about helping patients with a chronic disease that can 
be managed, it far exceeds the potential cost analysis. The university has a budget to get supplies 
for simulation lab and hopefully the budget for this project will be approved so we start the 
future of nurses advocating and helping manage a disease that can cause extreme complications 
and comorbidities. Death can occur from poorly managed diabetes. Giving patient the quality of 
life back and ability to stay out of the hospitals is a definite win in all the medical settings. 
Medicaid and Medicare will also be useful as diabetics are often older. If the cost of the CGM 
device prevents patients from continuous and repeated hospitalizations, then the healthcare 
industry will be behind the change project.  
Conclusions/Recommendations 
The reality is diabetes is a disease that requires effective monitoring to maintain safe 
glucose levels for patients.  When diabetes is not monitored effectively severe complications 
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arise that impact quality of life. From wounds to kidney disease the co-morbidities are vast.  The 
research done has indicated that CGM is safer, more efficient, and more effective for patients.  
There is significant evidence-based data supporting CGM over FGM. Considering the patient 
side of the device, ease of use and reliability will improve compliance and satisfaction. 
Physicians will also have increased data to use in creating an individualized, optimal care plan. 
Continued advances in healthcare will enhance the quality of life in patients on an individual and 
collective level.  
The clinical issue relating to glucose monitoring is important to continue to improve. 
Diabetes is chronic, requires frequent monitoring, and will cause multiple comorbidities if not 
properly treated. Not only does diabetes lead to more disease processes, it also complicates 
existing ones. Diabetes requires completely individualized treatments plans that use insulin to 
supplement the lack of, or oral antidiabetics that reduce blood glucose levels. Cost is an issue 
that is relevant to all health conditions. Until now glucose levels have required a needle stick and 
sample of blood multiple times a day for monitoring. Bruising, pain, and inconvenience are only 
a fraction of the issues a patient will experience for FGM. Carrying the equipment at all times as 
well as finding an appropriate place to check glucose in public can be difficult. Even then, 
hypoglycemia can happen unexpectedly. Cutting out blood samples in public places is a huge 
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